NCT05266209

Brief Summary

This study was planned to examine the effects of coconut and sunflower oils applied to the skin of newborns on the daily fluid intake and output of the baby, the weight gain/decrease status and skin integrity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

March 25, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2023

Completed
Last Updated

May 16, 2023

Status Verified

May 1, 2023

Enrollment Period

11 months

First QC Date

February 2, 2022

Last Update Submit

May 13, 2023

Conditions

Keywords

Coconut oilSunflower oilneonatalNeonatal Intensive Care Unitskin care

Outcome Measures

Primary Outcomes (2)

  • effect on skin integrity

    Evaluation with Newborn Skin Condition Evaluation Form (NSCE) form: Evaluations will be made using the YCDD form 48-72 hours after each application (Monday, Thursday, Sunday). Skin condition scoring of the newborn; It is performed according to the presence of signs of redness, dryness and deterioration of skin integrity/peeling. It was developed in a three-point Likert format and each item/finding is given a score from 1 to 3. The lowest score that can be obtained as a result of the evaluation is 3, and the highest score is 9. A total score higher than 3 indicates that there is a risk of deterioration of the skin integrity of the newborn, while a high score indicates that the newborn's skin condition is poor.

    Evaluation with Newborn Skin Condition Evaluation Form (NSCE) form: Evaluations will be made using the YCDD form 48-72 hours after each application (Monday, Thursday, Sunday).

  • the effect of the baby's weight gain/decrease on 7,14, 21, 28 days

    The baby's weight will be measured on days 7, 14, 21, 28, naked and without diapers.

    The scale is sensitive enough to measure in very small units.

Study Arms (3)

Experimental (coconut oil group)

EXPERIMENTAL

Before moistening, the skin of newborns is evaluated using the Newborn Skin Condition Evaluation Form form. Moisturizers are applied to the thorax, back, arms and legs by massage, respectively, and the skin is absorbed. If it is to be applied for the first time, it is applied to a small area of the body under the control of a doctor. If there is no reaction, it is applied by massaging other areas. Since the babies to be included in the sample group are borderline and moderately premature (34-37W), 3-4 ml/kg (coconut oil)moisturizer will be applied. Evaluation with NSCE form: Evaluations will be made using the NSCE form 48-72 hours after each application (Monday, Thursday, Sunday). Routine care will be applied to the skin of the newborns in the control group in the hospital. The control group will be evaluated using the NSCE form 3 days a week (Monday, Thursday, Sunday).

Other: Coconut oil skin care group

Experimental (sunflower oil group)

OTHER

Before moistening, the skin of newborns is evaluated using the Newborn Skin Condition Evaluation Form form. Moisturizers are applied to the thorax, back, arms and legs by massage, respectively, and the skin is absorbed. If it is to be applied for the first time, it is applied to a small area of the body under the control of a doctor. If there is no reaction, it is applied by massaging other areas. Since the babies to be included in the sample group are borderline and moderately premature (34-37W), 3-4 ml/kg (sunflower oil) moisturizer will be applied. Evaluation with NSCE form: Evaluations will be made using the NSCE form 48-72 hours after each application (Monday, Thursday, Sunday).

Other: Coconut oil skin care group

No Intervention (Control group)

NO INTERVENTION

Before moistening, the skin of newborns is evaluated using the Newborn Skin Condition Evaluation Form form. Routine maintenance of the intensive care unit will be implemented. Evaluation with NSCE form: Evaluations will be made using the NSCE form 48-72 hours after each application (Monday, Thursday, Sunday). Routine care will be applied to the skin of the newborns in the control group in the hospital. The control group will be evaluated using the NSCE form 3 days a week (Monday, Thursday, Sunday)

Interventions

No special technique was used for sample selection, random sample selection will be made. In the evaluation made according to the large effect size, the number of samples determined for Power: 0.80, :0.20 and :0.05 was determined as 66, with a minimum of 22 for each group. Calculations were made in computer environment using Power analysis (G\*Power 3.1.9.2) program. Random selection method will be used while creating research groups. Coconut oil, sunflower oil and control groups will be formed according to the order of admission to the unit. E.g; Coconut oil is planned for the first hospitalized newborn, sunflower oil for the second newborn, and third hospitalized newborn control group. This order will be repeated until a sufficient number of cases is reached when the newborns are included in the groups.

Also known as: sunflower oil skin care group
Experimental (coconut oil group)Experimental (sunflower oil group)

Eligibility Criteria

Age34 Weeks - 37 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Voluntary verbal and written consent of the parents of the newborn,
  • The gestational week of the newborn is 34 and above,
  • The birth weight of the newborn is 2000 g and above,
  • The hospitalization of the newborn is the first day of birth.

You may not qualify if:

  • Unstable clinical condition and vital signs,
  • Having a major congenital anomaly,
  • High risk of infection due to surgery,
  • More than 5% of the body surface is a skin disease,
  • External application of medication to the skin in its treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sakarya Education and Training Hospital

Sakarya, Adapazarı, 54050, Turkey (Türkiye)

Location

Study Officials

  • NURSAN ÇINAR, Prof

    Sakarya University

    PRINCIPAL INVESTIGATOR
  • HAMİDE ZENGİN, Asis Prof

    Bilecik Seyh Edebali Universitesi

    PRINCIPAL INVESTIGATOR
  • İBRAHİM CANER, Prof

    Sakarya University

    PRINCIPAL INVESTIGATOR
  • ERTUĞRUL GÜÇLÜ, Prof

    Sakarya University

    PRINCIPAL INVESTIGATOR
  • ÖZNUR TİRYAKİ, PhD

    Sakarya Education and Research Hospital

    PRINCIPAL INVESTIGATOR
  • MELTEM KARABAY, Asis Prof

    Sakarya University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The researcher is not blind since the group of infants will be assigned by the researcher in order. The statistician was also blinded for the data analysis purpose.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nurse

Study Record Dates

First Submitted

February 2, 2022

First Posted

March 4, 2022

Study Start

March 25, 2022

Primary Completion

February 25, 2023

Study Completion

May 12, 2023

Last Updated

May 16, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations